- Home /
- Press /
- Press releases
Press Releases
11-10-2021
Eckert & Ziegler Acquires 53,000 Square Feet Facility for Expansion of Contract Development and Manufacturing Services
27-09-2021
Nantes University Hospital Doses First Patients with Eckert & Ziegler's Novel Ga-68 Imaging Agent PENTIXAFOR
09-08-2021
Eckert & Ziegler Receives Manufacturing Authorization for Thorium and Lutetium Compounds
02-08-2021
Eckert & Ziegler Takes over Brazilian Isotope Specialists - Strengthening their Presence in South America
27-07-2021, 17:27 CEST (Ad hoc press release)
Half Year Results Stronger than Expected; Eckert & Ziegler Increases Profit Forecast by approximately 20%
08-06-2021
Eckert & Ziegler: Affiliate Receives Additional NIAID Funding to Advance Pharmaceutical Development
03-06-2021
Eckert & Ziegler and Telix Pharmaceuticals Enter Co-Promotion Agreement for Prostate Cancer Diagnostic in the United States
18-05-2021
Eckert & Ziegler Granted Exclusive Distribution Rights by Telix Pharmaceuticals for Prostate Cancer Diagnostic
17-05-2021
Eckert & Ziegler: Record Income Due to Sale of Division and Strong Core Business
28-04-2021
Eckert & Ziegler Signs Long-Term Supply Agreement with Sirtex Medical on Yttrium-90 for Treating Liver Cancer
16-04-2021, 11:01 CEST (Ad hoc press release)
Eckert & Ziegler Acquires Direct Majority Stake in Drug Developer PENTIXAPHARM
14-04-2021
Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin
12-04-2021, 21:12 CEST (Ad hoc press release)
Eckert & Ziegler Receives Technetium Generator Licenses for Brazil
25-03-2021, 19:52 CET (Ad hoc press release)
Eckert & Ziegler: Dividend Proposal EUR 0.45 per Share. Profit Increase in 2020. Positive Outlook for 2021.
24-03-2021, 14:09 CET (Ad hoc press release)
Eckert & Ziegler Divests From Tumour Irradiation Business
17-03-2021, 23:49 CET (Ad hoc press release)
Eckert & Ziegler 2020: Earnings higher than expected
12-02-2021
Eckert & Ziegler to Start Development of Radioisotope Production Facility in Jintan, PR China
04-02-2021, 19:28 CET (Ad hoc press release)
Eckert & Ziegler: PENTIXAPHARM Lead Candidate PENTIXAFOR Can Go in Phase III Study, EMA says
28-01-2021
Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in USA
12-01-2021
Eckert & Ziegler: Seed Implantation for Prostate Cancer Receives Reimbursement for Outpatient Care
